Provided by Tiger Fintech (Singapore) Pte. Ltd.

Day One Biopharmaceuticals Inc.

7.00
+0.39005.90%
Post-market: 7.010.0100+0.14%19:55 EDT
Volume:1.41M
Turnover:9.78M
Market Cap:709.54M
PE:-9.85
High:7.05
Open:6.68
Low:6.63
Close:6.61
Loading ...
May 01, 2023

Major Issues Report

8-K - Current report
May 01, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 20, 2023

Major Issues Report

8-K - Current report
Mar 20, 2023

Major Issues Report

8-K - Current report
Mar 06, 2023

Major Issues Report

8-K - Current report
Mar 06, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 23, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 03, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2023

Major Issues Report

8-K - Current report
Nov 07, 2022

Major Issues Report

8-K - Current report
Nov 07, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Oct 31, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Oct 19, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 22, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 19, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 12, 2022

Major Issues Report

8-K - Current report